A
Aerwave Medical
Health Tech & Medtech · New York City, United States · Founded 2020
Developing a unique alternative to traditional medications used to treat COPD and asthma MoreLess
AerWave Medical is at the forefront of transforming the treatment of pulmonary diseases such as asthma, Chronic Obstructive Pulmonary Disease (COPD), and other advanced lung conditions through an innovative interventional approach. The company targets patients suffering from these chronic respiratory conditions, providing them with alternatives to traditional medication-based treatments. Operating within the healthcare and medical technology market, AerWave Medical leverages cutting-edge research and development to create minimally invasive procedures that aim to improve patient outcomes and quality of life. The business model revolves around developing and commercializing these medical interventions, generating revenue through the sale of proprietary medical devices and therapies to healthcare providers and institutions. By focusing on unmet medical needs and harnessing a world-class management team, AerWave Medical positions itself as a leader in the pulmonary care sector.
Keywords: pulmonary disease, asthma, COPD, interventional therapy, medical technology, healthcare innovation, minimally invasive, chronic respiratory conditions, patient outcomes, proprietary devices.
Company overview
Aerwave Medical company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2020
- Headquarters
- New York City, United States
- Employees
- —
- Open positions
- None listed
- Dealroom signal
- 19.3
Valuation & funding
Aerwave Medical funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Jan 2025 | $12M | $48M | Undisclosed | ↗ |
| EARLY VCEquity / VC | Aug 2023 | $4M | $16M | Undisclosed | — |
| DEBT✓Debt | Jul 2022 | $245K | — | Undisclosed | ↗ |
| EARLY VC✓Equity / VC | Jul 2022 | $250K | $20M | Undisclosed | ↗ |
| SERIES A✓Equity / VC | Feb 2021 | $4M | $16M | Undisclosed | ↗ |
Growth signals
Aerwave Medical website traffic
Latest recorded traffic for Aerwave Medical is 730 monthly website visits, up 7200% over the last three months.
Comparisons
Aerwave Medical compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Aerwave Medical's talent
Source: Dealroom Talent Intelligence.
Investors
1 investor on Aerwave Medical's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Aerwave Medical has talent and traffic
In the news
Latest news about Aerwave Medical
Recent press, funding announcements, and product moves mentioning Aerwave Medical — open to read from the original sources.
Market sentiment
What the market is saying about Aerwave Medical
An AI-synthesized read of the highest-engagement posts about Aerwave Medical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Aerwave Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.